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ABSTRACT 
In recent years the increasing use of pharmaceuticals and personal-care products (PPCPs), especially antibiotics, 
has become a particular concern because of their undesirable potential ecological and human health effects. This 
study presents an environmental risk assessment for the aquatic environment of some frequently used antibiotics 
in Iran in three stages including; a short literature review about antibiotic consumption in Iran, a comprehensive 
estimation regarding acute toxicity of selected antibiotics and finally calculation of Risk Quotient (RQ) using 
the predicted environmental concentration (PEC) and the predicted no-effect concentration (PNEC). According 
to recently published data, the consumption of antibiotics in Iran is several times greater than European 
countries and in case of antibiotics (e.g. Penicillin) is approximately 10 times greater than Scandinavian region. 
The calculated PECs were ranged from 0.0071 to 0.8570 and the PNECs value based on ecotoxicity data was 
found for all studied antibiotics (varied from 0.0037 to 177). The RQ exceeded one for Amoxicillin, Penicillin 
G, Sulfamethoxazole, and Erythromycin.   Amoxicillin has the highest risk to aquatic organisms based on this 
study. With respect to the emergence of microbial resistance, it is important to begin monitoring the most 
frequently used antibiotics 
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INTRODUCTION 
Emerging contaminants (ECs) in the environment 
are a rapidly growing field of research. Within this 
field, pharmaceuticals and personal-care products 
(PPCPs) is an important subclass that are gaining 
interest in recent years [1]. Antibiotics are the most 
important groups of PPCPs being used in medicine, 
veterinary medicine, farming and aquaculture for 
the prevention and treatment of diseases [2]. After 
intake, pharmaceutically active compounds 
undergo metabolic processes in organisms. 
Significant fractions of the parent compound are 
excreted in unmetabolized form or as metabolites 
(active or inactive) into raw sewage and wastewater 
treatment systems [3-6]. Municipal sewage 
treatment plant effluents are discharged to water 
bodies or reused for irrigation, and produced 
biosolids are reused in agriculture as a soil 
amendment or disposed to landfill [7]  
Based on published data, the rate of antibiotic 
prescription in developed countries (e.g.15.3% in 
the USA) is much more than developing countries 
varying from 17.5% in Lebanon to 60% in Jordan 
[8]. In Iran, about 37.3% of urban households are 
connected to 136 sewage treatment plant (STP) via 
42390 km municipal sewers [9]. There is no 
national program or regulation for the collection of 
unused or expired drugs. However, it seems that 
many households dispose their drugs into toilets or 
garbage bins which ultimately end up in water 
bodies. In many countries the risk and effects of 
pharmaceuticals in the environment is known and 
some countries have regulations to limit their 
effects on the environment [10]. Despite the high 
consumption rate of PPCPs in Iran [11] there is no 
study on the risk assessment of PPCPs or 
antibiotics. This study aims to evaluate the 
environmental risk assessment for aquatic 
environments of some frequently used antibiotics 
in Iran. 
 
MATERIALS AND METHODS 
This study was conducted in three stages including; 
a short literature review about antibiotic 
consumption in Iran, a comprehensive estimation 
on the acute toxicity of selected antibiotics, and 
finally calculating the Risk Quotient (RQ) using 
predicted environmental concentration (PEC) and 
the predicted no-effect concentration (PNEC).  
The sold drug data were analyzed to determine the 
most used drugs in Iran using the data sheet 
published by the Iranian Ministry of Health [11]. 
Furthermore, a comprehensive review of the 
literature was done to find the most prescribed 
drugs.  
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The environmental risk assessment is based on the 
EU draft guideline document for medicinal 
products for human use [10], and an RQ was 
calculated between the PEC or measured 
environmental concentration (MEC) and the 
PNEC. The concentration of the active substance in 
the water (PECw) was calculated as equation1. [10, 
12, 13]: 
      (1) 
 
 Where, A is the amount used per year (kg/yr), R is 
the removal in percent (set to zero when 
information on biodegradation in the environment 
is missing or when worst-case conditions are 
assessed), P the number of inhabitants in Iran; 
75000000 in 2011 [14], V the volume of 
wastewater per day per capita (0.165 m3) and D is 
the dilution factor in the environment (a default 
factor of 10 is used). 
Acute toxicity data were made by the PNEC value 
from a short literature review as well as by using 
Structure Activity Relationships (SARs) predicted 
model ECOSAR (ECOWIN v1.11). To evaluate 
baseline toxicity for each antibiotic separately 
using the ECOSAR model, physicochemical 
properties of each antibiotic was evaluated from 
Estimation Program Interface (EPI) Suite software 
(USEPA) and then these values were imputed to 
ECOSAR model. Most SAR calculations in the 
ECOSAR Class Program are based upon the 
Octanol/water partition coefficient (Kow) and then 
to all other physicochemical parameters. The 
PNEC value was obtained by considering the 
lowest EC50 or LC50 [15]. The RQ is an indicator 
for ecotoxicological risk and is a ratio between 
PEC and PNEC for each substance. In cases that 
RQ is greater than 1, ecotoxicological risk for the 
aquatic environment is expected. Otherwise, the 
values of RQ less than 1 indicate no 
ecotoxicological risk for the specific aquatic 
environment [16].  
 
RESULTS 
Antibiotics consumption in Iran: 
Based on the research study, compared to three 
European countries (Denmark, Sweden, and 
Norway), the antibiotic consumption in Iran is 
several times higher (table 1) [17]. 
According to a published report about prescribed 
drugs in six large cities of Iran, the maximum and 
average number of prescribed drugs was 12.5 and 
3.2 respectively, while the patients who took the 
antibiotics varied from 47-59% [18]. A study 
conducted in Iran showed that in the first 6 months 
of 2000 and 2005, the antibiotic consumption was 
95.4 and 124 Defined Daily Dosis per 100 beds per 
day (DDD/100 bed-days) respectively [19]. Other 
studies also confirm that the antibiotic prescription 
rate is as high as 50 % (table 2). 
 
Table1: Consumption of some antibiotics in Iran and 
three European countries (No./1000 habitation year) [17] 
Pharmaceutical Denmark Sweden Norway Iran 
Penicillin 7.3 8 7.5 76.25 
Cephalosporins <0.05 - 0.366 2.71 
Trimethoprim 
Sulfamethoxazole 
0.8 0.9 1.45 8.95 
Aminoglicozide <0.05 <0.1 0.05 
60 
 
According to the Iranian Ministry of Health, the 
used active compound in terms of gram per capita 
and year ranged from 0.04-5.02 and the 7 primary 
used antibiotics in 2011 were consumed more than 
10 tons per year (table 3).  
Results of acute toxicity data  
For the selected antibiotics, acute toxicity data (i.e. 
PEC, PNEC and RQ values) were found with a 
very short comprehensive literature review. In 
some cases, these data were calculated using 
ECOSAR software (table 4). The toxicity of 
Amoxicillin, Penicillin G and Azithromycin were 
reported for just algae [24,25] and for cephalexin 
the test organism wasn’t mentioned in the related 
paper. In another study, Clavulanic Acid acute 
toxicity was reported 13.3 without any appointment 
to test organism [26]. Jones et al (2002) reported 
acute toxicity of Penicillin V for Daphnia test [27]. 
ECOSAR software was used for calculating the 
toxicity of the other active compounds (i.e. 
Trimethoprim, Sulfamethoxazole and 
Erythromycin) (table 4). As it was obvious, the 
maximum and minimum RQ were 232 and 0.00028 
for Amoxicillin and 0.00028 for penicillin V, 
respectively. 
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Table 2: Some conducted studies about antibiotics consumption pattern in Iran 
 
No of studied 
prescriptions 
City / Province Results Reference 
8019328 Ghazvin 
4 of 10 first prescribed drugs were antimicrobials, and 
Penicillin was the first 
[20] 
25700000 West Azerbaijan 
Amoxicilin500 mg, Ceftriaxone 1 g  and 
metronidazole 250 mg to 94.7, 67.4, and 23.4%,  
respectively, were among the first 10 prescribed drugs 
[21] 
12852901 Tehran 
More than 45% of prescriptions had at least 1 
antibiotic. Cephalosporin, Penicillin and Macrolides 
were the top 3 prescribed drugs respectively. They 
found that 5-10 drugs that had the most consumption 
in 2011 were antibiotics. 
[22] 
2000 Ardebil 
The total number of prescribed drugs was 7158. The 
average number of drugs for every prescription was 
3.58. Antibiotics were the top prescribed drugs with a 
frequency of 52.8%. 
[23] 
4463710 Isfahan 
51.25% of the patients received an antibiotic. 
Amoxicillin (5.9%) and Penicillin 6-3-3 (5.53%), 
followed by Cefixime (3.62%) and Azithromycin 
(2.74%) were among the top prescribed drugs 
[8] 
 
Table 3: The 7 most used Antibiotics in Iran in 2011 [11] 
 
No Active compound CAS-no. An amount Active 
compound used (Kg/year) 
An amount Active 
compound used 
(g/capita/year) 
1 Amoxicillin 026787-78-0 387,095 a 5.02 
2 Cephalexin 015686-71-2 109,227 1.41 
3 Co-Amoxiclav: 
Amoxicillin 
Clavulanic Acid 
 
026787-78-0 
058001-44-8 
48,104 
32,069 
16,035 
0.62 
0.41 
0.20 
4 Penicillin  V 
Penicillin G 
000087-08-1 
001538-09-6 
24,135 
14,763 
0.31 
0.19 
5 Co-Trimoxazole: 
Trimethoprim 
Sulfamethoxazole 
 
738-70-5 
723-46-6 
22,968 
3,190 
19,140 
0.29 
0.04 
0.24 
6 Azithromycin 83905-01-5 17,654 0.22 
7 Erythromycin 000114-07-8 10,402 0.13 
a: including the value in Co-Amoxiclav (row no.3)  
 
DISCUSSION 
The calculated PECs ranged from 0.0071 to 0.8570 
and the PNECs value based on ecotoxicity data was 
found for all studied antibiotics (varied from 
0.0037 to 177). 
The environmental risk assessment of the 7 most 
used antibiotics in Iran was done by calculating the 
risk quotient. As shown in the table 4, the RQ of 
Amoxicillin was 232. Moreover, according to 
Kümmerer (2008) it can cause an ecotoxicological 
risk to the aquatic environment [2]. This judgment 
was confirmed by Technical Guidance Document 
criteria [16].  
The RQ exceeded one for Amoxicillin, Penicillin 
G, Sulfamethoxazole, and Erythromycin and was 
below one for Cefalexin, Penicillin V, Clavulanic 
Acid, Trimethoprim, and Azithromycin. According 
to Technical Guidance Document (2003) criteria 
for 4 of 7 studied antibiotics, ecotoxicological risk 
can be expected [16]; while based on Kümmerer 
(2008) classification Trimethoprim, Penicillin V, 
and Cefalexin had insignificant risks, Azithromycin 
had lower risks, Penicillin G, Sulfamethoxazole, 
and Erythromycin had moderate risks and finally 
Amoxicillin had a high risk for aquatic organisms 
[2]. Some antibiotics (and more specially the 
studied antibiotics in this study), are sold over the 
counter and without any prescription. As a result, 
the consumption of these antibiotics may be higher 
in Iran.  
Excretion rates for the unchanged active compound 
in the antibiotics that are excreted into wastewater 
unchanged have varying ranges of 30 to 60 percent 
[32]. On average, if the volume of all the 
antibiotics used is totaled, the metabolic rate is 
30% [3]. Therefore, if we consider it for just 
Amoxicillin, it equals to more than 270 tons per 
year in Iran. Moreover, Amoxicillin is suspected to 
have direct toxicity to certain aquatic organisms 
such as algae. It is reported that the photosynthesis 
mechanism of algae Synechocystis sp is inhibited 
by the toxic effects of this compound. Amoxicillin 
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accumulates within single organisms (i.e. 
Pathogenic bacteria) and increase its resistance 
leading to higher dosage needed or even its 
incapability to treat conventional diseases [33]. Our 
results are only related to antibiotics consumed by 
humans. If we take the total antimicrobial use into 
account, the antibiotics that are released into the 
environment will be higher. 
 
Table 4: Top 7 Antibiotics ecotoxicological test results and PNECs 
 
Pharmaceutical 
Toxicity 
 
References PEC PNEC RQ 
Test 
organism 
Concentration 
Amoxicillin 
Algae EC 50,  0.0037 
EC 50  ,0.1 
[24] 
[25] 
0.8570 0.0037 232 
Cephalexin - 2.5 
 
[25] 
0.2418 2.5 0.096 
Co-Amoxiclav: 
 
Amoxicillin 
 
Clavulanic Acid 
Algae 
 
- 
EC 50,  0.0037 
EC 50  ,0.1 
- 
[24] 
[25] 
[26] 
0.8570 
 
0.0355 
0.0037 
 
13.3 
232 
 
0.0027 
Penicillin: 
 
Penicillin V: 
Penicillin G: 
Daphnia 
EC50  
Algae  
EC50, 177 
EC50,  0.006 
 
 
[27] 
[24] 
0.0534 
0.0327 
 
177 
0.006 
 
0.00028 
5 
Co-Trimoxazole:  
 
Trimethoprim 
 
 
 
 
 
 
 
 
Sulfamethoxazole 
 
 
 
 
 
 
Fish 
Daphnia 
Algae 
Fish 
Daphnia 
Daphnia 
Algae 
 Bacteria  
   
 
DAPHNIA  
DAPHNIA  
ALGAE 
FISH  
FISH  
DAPHNIA  
BACTERIA  
ALGAE 
 ALGAE  
 
ALGAE 
LC50 ECOSAR, 798 
LC50 ECOSAR, 4.5 
EC50 ECOSAR, 2.6 
EC50 ECOSAR, 795 
EC50 ECOSAR, 121 
EC50, 123 
EC50 ECOSAR, 2.6 
EC50 (15 min), 177 
 
 
EC50 ECOSAR 4.5 
LC50 ECOSAR, 1.87 
EC50 ECOSAR,  51 
LC50 ECOSAR, 413 
EC50 (96 h) 563 
EC50 (48 h-mortality) >100 
EC50 (15 min) 78.1 
EC50 (96 h-growth) 0.15 
EC50 (96 h‐growth) 0.027 
EC50 ECOSAR, 6.6 
Authors 
Authors 
Authors 
[28] 
[29] 
[24] 
[28] 
[29] 
 
 
[28] 
Authors 
[28] 
Authors 
[29] 
[30] 
[29] 
[30] 
[30] 
 
Authors 
 
 
 
 
 
 
0.0071 
 
 
 
0.0424 
 
 
 
 
 
2.6 
 
 
 
0.027 
 
 
 
 
 
 
0.0038 
 
 
 
1.48 
Azithromycin Green Algae EC50 , 0.15 mg/L 
[25] 
 
0.0391 0.15 0.26 
Erythromycin 
 
 
 
Fish 
Fish 
Daphnia 
Algae 
Invertebrates 
Algae 
Daphnia 
Algae 
LC50 ECOSAR,2.84 
EC50 ECOSAR 61 
EC50 ECOSAR 7.8 
EC50 ECOSAR 4.3 
EC50 15 
EC50 0.02 
LC50 ECOSAR,3.8 
EC50 ECOSAR,2.5 
 
Authors 
 
[28] 
 
[28] 
 
[28] 
 
[31] 
 
[31] 
 
Authors 
Authors 
0.023 0.02 1.15 
 
DISCUSSION 
The calculated PECs ranged from 0.0071 to 0.8570 
and the PNECs value based on ecotoxicity data was 
found for all studied antibiotics (varied from 
0.0037 to 177). 
The environmental risk assessment of the 7 most 
used antibiotics in Iran was done by calculating the 
risk quotient. As shown in the table 4, the RQ of 
Amoxicillin was 232. Moreover, according to 
Kümmerer (2008) it can cause an ecotoxicological 
risk to the aquatic environment [2]. This judgment 
was confirmed by Technical Guidance Document 
criteria [16].  
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The RQ exceeded one for Amoxicillin, Penicillin 
G, Sulfamethoxazole, and Erythromycin and was 
below one for Cefalexin, Penicillin V, Clavulanic 
Acid, Trimethoprim, and Azithromycin. According 
to Technical Guidance Document (2003) criteria 
for 4 of 7 studied antibiotics, ecotoxicological risk 
can be expected [16]; while based on Kümmerer 
(2008) classification Trimethoprim, Penicillin V, 
and Cefalexin had insignificant risks, Azithromycin 
had lower risks, Penicillin G, Sulfamethoxazole, 
and Erythromycin had moderate risks and finally 
Amoxicillin had a high risk for aquatic organisms 
[2]. Some antibiotics (and more specially the 
studied antibiotics in this study), are sold over the 
counter and without any prescription. As a result, 
the consumption of these antibiotics may be higher 
in Iran.  
Excretion rates for the unchanged active compound 
in the antibiotics that are excreted into wastewater 
unchanged have varying ranges of 30 to 60 percent 
[32]. On average, if the volume of all the 
antibiotics used is totaled, the metabolic rate is 
30% [3]. Therefore, if we consider it for just 
Amoxicillin, it equals to more than 270 tons per 
year in Iran. Moreover, Amoxicillin is suspected to 
have direct toxicity to certain aquatic organisms 
such as algae. It is reported that the photosynthesis 
mechanism of algae Synechocystis sp is inhibited 
by the toxic effects of this compound. Amoxicillin 
accumulates within single organisms (i.e. 
Pathogenic bacteria) and increase its resistance 
leading to higher dosage needed or even its 
incapability to treat conventional diseases [33]. Our 
results are only related to antibiotics consumed by 
humans. If we take the total antimicrobial use into 
account, the antibiotics that are released into the 
environment will be higher. 
 
CONCLUSION 
Finally, according to present study the antibiotics 
roll in the environmental toxicity is considerably 
so, with respect to the emergence of microbial 
resistance, it is important to begin monitoring the 
most frequently used antibiotics, especially those 
who have higher environmental risk, such as 
Amoxicillin. Using labels such as “harmful to the 
environment” could be useful.  Moreover, public 
education and restrictions for the sale of drugs 
without prescription could be effective.   
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